Bone Marrow Transplantation

Top Story

Model used to estimate link between radiation, cancer must be re-evaluated

Model used to estimate link between radiation, cancer must be re-evaluated
May 29, 2016

Previous investigations conducted by the founders of the linear no-threshold model with respect to genetic effects and carcinogenesis represent “one of the greatest misapprehensions and oversight failures within the scientific research community,” according to authors of a study review published in American Journal of Clinical Oncology.

Five updates for World Blood Cancer Day

May 28, 2016
DKMS, an international nonprofit organization, founded World Blood Cancer Day in 2014.World Blood Cancer Day — observed on May 28 — is designed to raise…
In the Journals

Assessment tool may identify older patients at risk for chemotherapy toxicity

May 27, 2016
An assessment tool comprised of clinically relevant questions and specific treatment information accurately predicted risk for chemotherapy toxicity in a majority of…
FDA News

FDA approves first CMV test for hematopoietic stem cell transplant recipients

May 25, 2016
The FDA approved the first in vitro diagnostic test used to monitor cytomegalovirus treatment in hematopoietic stem cell transplant recipients, according to a press…
CME

The Patient with Castration-resistant Prostate Cancer

No commercial support for this activity.

Castration-resistant prostate cancer (CRPC) is a heterogeneous condition that encompasses a continuum of disease…
More »
Video
Meeting News Coverage

CD19-targeted T-cells show potential in B-ALL, allogeneic stem cell transplantation

June 19, 2014
More »
Featured
AACR Annual Meeting

AACR Annual Meeting

CME

The Patient with Myelofibrosis

No commercial support for this activity.

Myelofibrosis is caused by abnormal stem cells in the bone marrow that cause the uncontrolled production of mature…
More »

Model used to estimate link between radiation, cancer must be re-evaluated

May 29, 2016
Previous investigations conducted by the founders of the linear no-threshold model with respect to genetic effects and carcinogenesis represent…

Five updates for World Blood Cancer Day

May 28, 2016
DKMS, an international nonprofit organization, founded World Blood Cancer Day in 2014.World Blood Cancer Day — observed on May 28 — is…

In the Journals

Assessment tool may identify older patients at risk for chemotherapy toxicity

May 27, 2016
An assessment tool comprised of clinically relevant questions and specific treatment information accurately predicted risk for chemotherapy toxicity…

FDA News

FDA approves first CMV test for hematopoietic stem cell transplant recipients

May 25, 2016
The FDA approved the first in vitro diagnostic test used to monitor cytomegalovirus treatment in hematopoietic stem cell transplant recipients…

‘Surge’ in unnecessary CT scans significantly increases cancer risks

May 23, 2016
A single standard CT scan may increase the risk for fatal cancer in one of every 2,000 patients, according to FDA data.Repeat or excessive exposure…

In the JournalsPerspective

Lifestyle changes can reduce cancer incidence, mortality

May 20, 2016
The adoption of healthy lifestyle practices may prevent a large proportion of cancers and reduce cancer mortality in the United States, according to…

Meeting News Coverage

CHG wipes may lower rates of central line-associated bloodstream infections

May 20, 2016
The use of chlorhexidine gluconate wipes for patient hygiene may lower central line-associated bloodstream infection rates among patients with…

Meeting News CoveragePerspective

Precision medicine approach improves outcomes in phase 1 trials

May 19, 2016
Patients treated in phase 1 trials designed with a biomarker-based approach for treatment selection demonstrated higher response rates and longer…

Congressional subcommittee debates Medicare Part B demonstration project

May 17, 2016
The U.S. House Energy Subcommittee on Health today held a hearing to offer doctor and patient perspectives on planned changes to the Medicare Part B…

FDA News

FDA grants accelerated approval to Opdivo for classical Hodgkin lymphoma

May 17, 2016
The FDA today granted accelerated approval to nivolumab for treatment of certain patients with classical Hodgkin lymphoma.Nivolumab (Opdivo…

More Headlines »
morganatic-roan